8 April, 2010: MEDRAD, Inc. Announces Supply Agreement with ev3 Inc. in Preparation for DEFINITIVE AR Pilot Trial
 
8 April, 2010 - Groundbreaking Study Will Evaluate the Combination of Hawk Plaque Excision and the Cotavance Drug-Eluting Angioplasty Balloon for the Treatment of Lower Extremity Peripheral Arterial Disease.
For more:
http://bmctoday.net/evtoday/2010/04/article.asp?f=trial-to-evaluate-medrads-cotavance-drug-eluting-balloon-combined-with-ev3s-plaque-excision-systems
|